Insmed | INSM - Vermögenswerte





Vermögenswerte Veränderung Datum
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Cytokinetics USD 1.27B 151.06M 2026-03
DBV Technologies USD 233.72M 123.22M 2025-12
Gilead Sciences USD 56.28B 2.74B 2026-03
Heron Therapeutics USD 246.22M 9.66M 2026-03
Insmed USD 2.08B 188.7M 2026-03
Novartis USD 110.95B 3.66B 2025-12
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03